NEW YORK (GenomeWeb News) — Agilent Technologies plans to acquire Stratagene for around $246 million in cash, the companies said today.
 
Separately, Stratagene CEO Joseph Sorge plans to form a new company that will pay $6.6 million for some of Stratagene’s molecular diagnostics assets.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.